Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors

被引：0
|
作者：
Iris Y. Sheng
Shilpa Gupta
Chandana A. Reddy
Dana Angelini
Pauline Funchain
Tamara A. Sussman
Joseph Sleiman
Moshe C. Ornstein
Keith McCrae
Alok A. Khorana
机构：
[1] Beth Israel Lahey Mt. Auburn Hospital,Department of Medicine
[2] Cleveland Clinic Taussig Cancer Institute,Department of Hematology and Medical Oncology
[3] Cleveland Clinic Taussig Cancer Institute,Department of Radiation Oncology
[4] Department of Medical Oncology,Department of Gastroenterology
[5] Dana Farber Cancer Institute,undefined
[6] University of Pittsburgh Medical Center,undefined
来源：
Targeted Oncology | 2022年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：563 / 569
页数：6
相关论文
共 50 条
  • [1] Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors
    Sheng, Iris Y.
    Gupta, Shilpa
    Reddy, Chandana A.
    Angelini, Dana
    Funchain, Pauline
    Sussman, Tamara A.
    Sleiman, Joseph
    Ornstein, Moshe C.
    McCrae, Keith
    Khorana, Alok A.
    TARGETED ONCOLOGY, 2022, 17 (05) : 563 - 569
  • [2] Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors
    Nuzzo, Pier Vitale
    Pond, Gregory R.
    Abou Alaiwi, Sarah
    Nassar, Amin H.
    Flippot, Ronan
    Curran, Catherine
    Kilbridge, Kerry L.
    Wei, Xiao X.
    McGregor, Bradley A.
    Choueiri, Toni
    Harshman, Lauren C.
    Sonpavde, Guru
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [3] Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors
    Shabto, Julie M.
    Martini, Dylan J.
    Liu, Yuan
    Ravindranathan, Deepak
    Brown, Jacqueline
    Hitron, Emilie E.
    Russler, Greta A.
    Caulfield, Sarah
    Kissick, Haydn
    Alemozaffar, Mehrdad
    Ogan, Kenneth
    Harris, Wayne B.
    Master, Viraj A.
    Kucuk, Omer
    Carthon, Bradley C.
    Bilen, Mehmet A.
    CANCER MEDICINE, 2020, 9 (08): : 2752 - 2760
  • [4] Risk of Venous Thromboembolism in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors
    Attia, Doaa
    Wei, Wei
    Pennell, Nathan A.
    McCrae, Keith R.
    Khorana, Alok A.
    Patil, Pradnya
    BLOOD, 2021, 138
  • [5] Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
    Oppolzer, Immanuel Augustin
    Riester, Josef
    Buettner, Roland
    Burger, Maximilian
    Schnabel, Marco Julius
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (08) : 1943 - 1949
  • [6] Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
    Immanuel Augustin Oppolzer
    Josef Riester
    Roland Büttner
    Maximilian Burger
    Marco Julius Schnabel
    International Urology and Nephrology, 2023, 55 : 1943 - 1949
  • [7] Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer
    Zhu, Alec
    Garcia, Jorge Alberto
    Faltas, Bishoy
    Grivas, Petros
    Barata, Pedro
    Shoag, Jonathan E.
    JAMA NETWORK OPEN, 2023, 6 (04)
  • [8] Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Zou, Xue-lin
    Chen, Wei-yong
    Zhang, Guang-yan
    Ke, Hua
    Yang, Qiu-hong
    Li, Xiao-bo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors
    Overvad, T. F.
    Ording, A. G.
    Nielsen, P. B.
    Piazza, G.
    Noble, S.
    Larsen, T. B.
    Skjoth, F.
    THROMBOSIS RESEARCH, 2022, 213 : S4 - S5
  • [10] Validation of the VIO prognostic index in patients with metastatic urothelial carcinoma treated with immune-checkpoint inhibitors
    Morales Barrera, R.
    Matos, I.
    Gonzalez, M.
    Suarez, C.
    Ros, J.
    Valverde, C.
    Fernandez, C.
    Hierro, C.
    Serra, E.
    Mateo, J.
    Gutierrez, S.
    Martin Liberal, J.
    Quintana, A.
    Dienstmann, R.
    Serrano, C.
    Garralda, E.
    Carles, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 369 - +
12345